Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Dyslipidemia

Free Subscription Articles published in Am Heart J Retrieve available abstracts of 6 articles: HTML format

Single Articles

July 2022
1. SHAH N, Ghazi L, Yamamoto Y, Martin M, et al
   Rationale and Design of a Pragmatic Trial Aimed at Improving Treatment of Hyperlipidemia in Outpatients with Very High Risk Atherosclerotic Cardiovascular Disease: A PRagmatic Trial Of Messaging to Providers about Treatment of HyperLIPIDemia (PROMPT-L
   Am Heart J. 2022 Jul 13. pii: S0002-8703(22)00146.
   PubMed     Abstract available
   
   
   May 2022
2. PERSSON LINDELL O, Karlsson LO, Nilsson S, Charitakis E, et al
   Clinical decision support for familial hypercholesterolemia (CDS-FH): Rationale and design of a cluster randomized trial in primary care.
   Am Heart J. 2022;247:132-148.
   PubMed     Abstract available
   
   
   October 2021
3. REDDY NK, Kaushal V, Kanaya AM, Kandula NR, et al
   Cardiovascular risk factor profiles in North and South Indian and Pakistani Americans: The MASALA Study.
   Am Heart J. 2021 Oct 21. pii: S0002-8703(21)00367.
   PubMed     Abstract available
   
   
   May 2021
4. SHI X, He J, Lin M, Liu C, et al
   Comparative effectiveness of team-based care with a clinical decision support system versus team-based care alone on cardiovascular risk reduction among patients with diabetes: Rationale and design of the D4C trial.
   Am Heart J. 2021 May 3. pii: S0002-8703(21)00111.
   PubMed     Abstract available
   
   
   January 2021
5. YANKEY GS, Jackson LR, Marts C, Chiswell K, et al
   African American-Caucasian American Differences in Aortic Valve Replacement in Patients with Severe Aortic Stenosis: Racial Differences in AVR.
   Am Heart J. 2021 Jan 13. pii: S0002-8703(21)00009.
   PubMed     Abstract available
   
   
   
6. ZACHARIAH JP, Shittu T, Wang Y
   Lipid temporal trends in normal-weight youth.
   Am Heart J. 2021;231:68-72.
   PubMed     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: